Frontage Holdings Corporation operates as a biotechnology company. The Company offers clinical trials, bioequivalence studies, medical writing, and agrochemical services. Frontage Holdings serves customers in Hong Kong.

Documents On Display

Notification Letter And Request Form For Non-Registered Holders

Notification Letter And Reply Form For Registered Holders

Form Of Proxy For The Extraordinary General Meeting
To Be Held At Building 2, No. 1227 Zhangheng Road,
Zhangjiang Hi-Tech Park, Shanghai, China On
Wednesday, January 7, 2026 At 10: 00 A.M.

Announcements and Notices - [Notice of EGM/SGM / Closure of Books or Change of Book Closure Period]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Frontage Holdings (1521 HK)

Documents On Display

Notification Letter And Request Form For Non-Registered Holders

Notification Letter And Reply Form For Registered Holders

Form Of Proxy For The Extraordinary General Meeting To Be Held At Building 2, No. 1227 Zhangheng Road, Zhangjiang Hi-Tech Park, Shanghai, China On Wednesday, January 7, 2026 At 10: 00 A.M.

Notice Of Extraordinary General Meeting

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)